Dyne Therapeutics Stock Market Value
DYN Stock | USD 33.01 2.05 6.62% |
Symbol | Dyne |
Dyne Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne Therapeutics. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dyne Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Dyne Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Dyne Therapeutics.
03/14/2024 |
| 06/12/2024 |
If you would invest 0.00 in Dyne Therapeutics on March 14, 2024 and sell it all today you would earn a total of 0.00 from holding Dyne Therapeutics or generate 0.0% return on investment in Dyne Therapeutics over 90 days. Dyne Therapeutics is related to or competes with Stoke Therapeutics, Pliant Therapeutics, Cytokinetics, Revolution Medicines, Edgewise Therapeutics, Cullinan Oncology, and Mineralys Therapeutics. Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therape... More
Dyne Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Dyne Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Dyne Therapeutics upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 3.91 | |||
Information Ratio | 0.0989 | |||
Maximum Drawdown | 35.59 | |||
Value At Risk | (6.11) | |||
Potential Upside | 6.07 |
Dyne Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Dyne Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Dyne Therapeutics' standard deviation. In reality, there are many statistical measures that can use Dyne Therapeutics historical prices to predict the future Dyne Therapeutics' volatility.Risk Adjusted Performance | 0.0722 | |||
Jensen Alpha | 0.4795 | |||
Total Risk Alpha | 0.4587 | |||
Sortino Ratio | 0.1241 | |||
Treynor Ratio | 0.1883 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Dyne Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Dyne Therapeutics Backtested Returns
Dyne Therapeutics appears to be not too volatile, given 3 months investment horizon. Dyne Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0911, which denotes the company had a 0.0911% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Dyne Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Dyne Therapeutics' Mean Deviation of 3.19, downside deviation of 3.91, and Coefficient Of Variation of 983.39 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Dyne Therapeutics holds a performance score of 7. The firm shows a Beta (market volatility) of 2.6, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Dyne Therapeutics will likely underperform. Please check Dyne Therapeutics' semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Dyne Therapeutics' price patterns will revert.
Auto-correlation | -0.59 |
Good reverse predictability
Dyne Therapeutics has good reverse predictability. Overlapping area represents the amount of predictability between Dyne Therapeutics time series from 14th of March 2024 to 28th of April 2024 and 28th of April 2024 to 12th of June 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Dyne Therapeutics price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Dyne Therapeutics price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.59 | |
Spearman Rank Test | -0.73 | |
Residual Average | 0.0 | |
Price Variance | 8.24 |
Dyne Therapeutics lagged returns against current returns
Autocorrelation, which is Dyne Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Dyne Therapeutics' stock expected returns. We can calculate the autocorrelation of Dyne Therapeutics returns to help us make a trade decision. For example, suppose you find that Dyne Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Dyne Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Dyne Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Dyne Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Dyne Therapeutics stock over time.
Current vs Lagged Prices |
Timeline |
Dyne Therapeutics Lagged Returns
When evaluating Dyne Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Dyne Therapeutics stock have on its future price. Dyne Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Dyne Therapeutics autocorrelation shows the relationship between Dyne Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Dyne Therapeutics.
Regressed Prices |
Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Information and Resources on Investing in Dyne Stock
When determining whether Dyne Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dyne Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dyne Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dyne Therapeutics Stock:Check out Dyne Therapeutics Correlation, Dyne Therapeutics Volatility and Dyne Therapeutics Alpha and Beta module to complement your research on Dyne Therapeutics. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Dyne Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.